Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma.
暂无分享，去创建一个
M. Dimopoulos | A. Palumbo | A. Jakubowiak | D. Siegel | R. Hájek | A. Oriol | P. Moreau | A. Stewart | H. Ludwig | K. Cocks | T. Masszi | J. San-Miguel | L. Rosiñol | I. Špička | R. Niesvizky | X. Yang | M. Tonda | B. Xing | N. Zojwalla | J. Buchanan | A. Stewart